Compare RGEN & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | RRC |
|---|---|---|
| Founded | 1981 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.7B |
| IPO Year | N/A | N/A |
| Metric | RGEN | RRC |
|---|---|---|
| Price | $156.66 | $36.31 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 18 |
| Target Price | ★ $170.90 | $41.94 |
| AVG Volume (30 Days) | 724.0K | ★ 3.1M |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | N/A | ★ 19.84 |
| EPS | 0.03 | ★ 2.38 |
| Revenue | $707,890,000.00 | ★ $2,891,506,000.00 |
| Revenue This Year | $17.84 | $28.16 |
| Revenue Next Year | $12.57 | $11.34 |
| P/E Ratio | $5,097.58 | ★ $15.32 |
| Revenue Growth | 11.74 | ★ 24.57 |
| 52 Week Low | $102.97 | $30.32 |
| 52 Week High | $182.52 | $43.50 |
| Indicator | RGEN | RRC |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 40.89 |
| Support Level | $160.11 | $38.07 |
| Resistance Level | $165.02 | $40.88 |
| Average True Range (ATR) | 4.97 | 1.09 |
| MACD | -1.27 | -0.35 |
| Stochastic Oscillator | 7.12 | 13.27 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.